NewBiologix

Epalinges, Switzerland

NewBiologix operates as a technology innovation company.

$50.3M raised

May 2023

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NewBiologix raised?

NewBiologix has raised $50.3M in total funding. The most recent round was Series A. The last funding was announced in May 2023.

Who are NewBiologix's investors?

NewBiologix's investors include Recipharm Venture Fund, Igor Fish, Nicolas Mermod.

Where is NewBiologix headquartered?

NewBiologix is headquartered in Epalinges, Switzerland.

What does NewBiologix do?

NewBiologix operates as a technology innovation company.

What stage is NewBiologix at?

NewBiologix is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 11, 2023.

MLA

"NewBiologix — Funding & Investors." VCBacked, May 11, 2023, https://www.vcbacked.co/company/newbiologix. Accessed July 2, 2026.

APA

VCBacked. (2023). NewBiologix — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/newbiologix

Wikipedia (cite web)

{{cite web |title=NewBiologix — Funding & Investors |url=https://www.vcbacked.co/company/newbiologix |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 11, 2023.